Tag: treatment for non-cystic fibrosis

FDA approves Insmed’s Brinsocatib as first treatment for non-cystic fibrosis bronchiectasis

The U.S. Food and Drug Administration (FDA) has approved Insmed's brensocatib as the first treatment for non-cystic fibrosis bronchiectasis (NCFBE) in adults and children aged 12 and older. Brensocatib, marketed…